Clinical Trial Update: VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?" [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether rate-responsive implantable cardioverter-defibrillators reduce ventricular arrhythmic episodes in patients with ventric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Fibrillation

Snippet

Sponsor: Guidant Corporation | Conditions: Ventricular Fibrillation | Phase 4 | Status: COMPLETED